Atlas Trials

Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection

Clinical trial NCT05229991 · COMPLETED

Trial details

NCT number
NCT05229991
Sponsor
Soroka University Medical Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis D, Chronic
Start date
2021-05-15
Primary completion
2025-02-05
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.